Ashok K. Srivastava (ed.) / Jean-Louis Chiasson

Vanadium Compounds: Biochemical and Therapeutic Applications

Herausgeber: Chiasson, Jean-Louis, Srivastava, Ashok K.

• Gebundenes Buch

Produktbeschreibung

The papers in this volume comprise invited reviews as well as original research papers presented at the Vanadium Symposium held July 29-31, 1994.
Vanadium is a trace element and its compounds have been shown to exert a wide variety of insulin-like effects including the ability to lower hyperglycemia in several experimental models of diabetes mellitus. Because of the possibility that vanadium compounds may be able to serve as potential therapeutic agents for the treatment of diabetes, and possibly other diseases, this trace element has attracted the attention of biomedical researchers from a variety of fields. The Vanadium Symposium 1994 was therefore organized to facilitate exchange of ideas and increase interaction among researchers of different disciplines actively engaged in studying the biological actions of vanadium compounds.
The papers are written by leading vanadium researchers and are grouped into three main sections: the chemistry, biochemical and physiological aspects, and potential therapeutic use and toxic effects of vanadium compounds. A good source of information on vanadium chemistry and biology.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Developments in Molecular and Cellular Biochemistry Vol. 16
• Verlag: Springer, Berlin
• 1995.
• Seitenzahl: 252
• Erscheinungstermin: 30. April 1996
• Englisch
• Abmessung: 286mm x 215mm x 19mm
• Gewicht: 876g
• ISBN-13: 9780792337621
• ISBN-10: 079233762X
• Artikelnr.: 23107098

Inhaltsangabe

Preface; A.K. Srivastava, J.-L. Chiasson. Chemistry. The chemistry of peroxovanadium compounds relevant to insulin mimesis; A. Shaver, et al. Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents; D.C. Crans, et al. Peroxo heteroligand vanadates(V): synthesis, spectra-structure relationships, and stability toward decomposition; C. Djordjevic, et al. Chemically and photochemically initiated DNA cleavage by an insulin- mimetic bis peroxovanadium complex; C. Hiort, et al. Biochemical and physiological studies. Insulin-like actions of vanadate are mediated in an insulin- receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases; Y. Shechter, et al. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis; A.P. Bevan, et al. Unique and selective mitogenic effects of vanadate on SV40-transformed cells; H. Wang, R.E. Scott. Vanadium compounds stimulate mitogen-activated protein (MAP) kinases and rebosomal S 6 kinases; S.K. Pandey, et al. Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart; T. Matsubara, et al. In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals; R.L. Khandelwal, S. Pugazthenthi. The relationship between insulin and vanadium metabolism in insulin target tissues; F.G. Hamel, W.C. Duckworth. Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signalling; I.G. Fantus, et al. Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction by vanadyl sulfate therapy; M.B. Anand-Srivastava, et al. Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of type I and type II diabetes; S.M. Brichard. Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver; S. Pugazthenthi, et al. Evidence for selective effects of vanadium on adipose cell metabolism involving actions on cAMP-dependent protein kinase; R.W. Brownsey, et al. The enhancement of pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membrane-associated tyrosine phosphatases; M. Boissoneault, et al. Contractile effects of vanadate on aorta rings from virgin and pregnant rats; J. St-Louis, et al. In vivo modulation of N - myristoyltransferase activity by orthovanadate; M.J. King, et al. Regulation and control of glucose overutilization in erythrocytes by vanadate; N.Z. Baquer, et al. In vitro and in vivo antineoplastic effects of orthovanadate; T.F. Cruz, et al. Membrane&endash;vanadium interaction: a toxicokinetic evaluation; R.K. Upreti. Potential use in therapy and toxicological studies. Increased potency of vanadium using organic ligands; J.H. McNeill, et al. In vivo effects of peroxovanadium compounds in BB rats; J.-F. Yale, et al. Long-term antidiabetic activity of vanadyl after treatment with withdrawal restoration of insulin secretion; G. Cros, et al. Long-term correction of STZ-diabetic rats after short-term i.p. VOSO 4 treatment: persistence on insulin secreting capacities assessed by isolated pancreas studies; P. Poucheret, et al. Antihypertensive effects of vanadium compounds in hyperinsilinemic, hypertensive rats; S. Bhanot, et al. Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation; J.L. Domingo, et al.